bemotrizinol
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 23, 2022 (NCT05260359)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUltraviolet filter
Ultraviolet filter
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05254912 | Phase 2 | Mar 7, 2022 | DSM, Eurofins |
| NCT05254925 | Phase 2 | Feb 28, 2022 | DSM, Eurofins |
| NCT05260359 | Phase 2 | Feb 23, 2022 | DSM, Eurofins |
Showing 3 of 3 trials
Page 1 / 1